TABLE 1

Microsomal and hepatocyte CLint and CLH predictions and observed values for eight benzodiazepines

Values are mean ± S.D. (n = 4-8).


Compound

Log P

Microsomesa

Hepatocytesb

In vivo

fup

Blood/Plasma Ratio
In Vitro CLint(u)
Microsomal fu
Predicted CLint
Predicted CLH
In Vitro CLint
Predicted CLint
Predicted CLH
Observed CLint
Observed CLHc
μl/min/mg ml/min μl/min/106 cells ml/min ml/min
Alprazolam 2.48 42 ± 20 1 27 ± 13 4.8 ± 1.9 30 ± 17 36 ± 21 5.8 ± 2.5 103 12 0.35 1.6
Chlordiazepoxide 2.44 4.5 ± 1.1 1d 3.0 ± 0.7 0.3 ± 0.07 9.6 ± 4.7 12 ± 5.6 1.2 ± 0.6 18 1.8 0.15 1.4
Clobazam 0.95 110 ± 34 1d 73 ± 22 8.1 ± 1.6 27 ± 13 32 ± 16 4.3 ± 1.8 50 6.3 0.21 1.3
Clonazepam 2.40 97 ± 9.7 0.76 64 ± 6.4 6.9 ± 0.5 17 ± 1.9 20 ± 2.3 2.7 ± 0.3 27 3.4 0.21 1.4
Diazepam 2.99 250 ± 72 0.93 170 ± 48 11 ± 1.6 160 ± 14 191 ± 16 12 ± 0.5 250 14 0.15 1.2
Flunitrazepam 2.06 87 ± 30 1 58 ± 20 7.8 ± 1.7 48 ± 32 57 ± 38 7.4 ± 3.2 80 9.8 0.25 1.2
Midazolam 3.40 99 ± 21 0.63 65 ± 14 3.8 ± 0.7 74 ± 11 88 ± 13 4.9 ± 0.6 250 10 0.07 1
Triazolam
2.42
230 ± 29
0.84
150 ± 20
13 ± 0.8
170 ± 57
200 ± 68
15 ± 1.9
160
14
0.28
1.5
  • a All microsomal incubations were performed at 1 mg of protein/ml with the exception of diazepam (0.5 mg/ml).

  • b All hepatocyte incubations were performed at 0.5 × 106 cells/ml.

  • c Expressed as blood clearance [blood clearance = plasma clearance/(blood/plasma ratio)]; data from Ito and Houston (2004).

  • d Values are assumed since their log P values are less than those for alprazolam and flunitrazepam.